Live Breaking News & Updates on Joel Latham|Page 7

Stay updated with breaking news from Joel latham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed

Review of IND Application for IHL-42X by US FDA has been completed; Clinical Trial for Patients with Obstructive Sleep Apnoea May Proceed
sina.com.hk - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sina.com.hk Daily Mail and Mail on Sunday newspapers.

United States , Joel Latham , Edison Group , Drug Administration , Incannex Healthcare Limited Nasdaq , Incannex Healthcare , Australian Stock Exchange , Continuous Positive Airway Pressure , Company Investigational New Drug , Incannex Healthcare Limited , Investigational New Drug , Apnea Hypopnea Index , Incannex Board , Obstructive Sleep Apnoea , American Depository Shares , Securities Litigation Reform Act , Chief Executive , Relations Contact ,

Public Announcement (NASDAQ: IXHL) (ASX

Public Announcement

Incannex to Conduct Shareholder Information Events Regarding Redomicile from Australia to United States

.
-Today at 06:12 am- MarketScreener ....

United States , Western Australia , New South Wales , Joel Latham , Incannex Healthcare , Edison Group , Australian Stock Exchange , Incannex Healthcare Limited Nasdaq , Incannex Healthcare Limited , Public Announcement , Healthcare Limited , Person Shareholder Meetings , Location Information , Shareholder Participation , Incannex Board , Rialto South Tower , American Depository Shares , Securities Litigation Reform Act , Chief Executive Officer , Relations Contact ,

Incannex Healthcare : Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Clarion Clinics Begins Accepting Registrations for Psychedelic Treatment Interest as Part of Pre-Screening in Readiness for Opening

Highlights:

. ....

New South Wales , United States , Joel Latham , Paul Liknaitzky , Sean Ocarroll , Suresh Sundram , Peter Widdows Incannex , Therapeutic Goods Administration , Edison Group , Incannex Healthcare Ltd Nasdaq , Zealand College Of Psychiatrists , Incannex Healthcare , Clarion Clinics Group Pty Ltd , Australian Stock Exchange , Clarion Clinics Begins Accepting Registrations , Psychedelic Treatment Interest , Authorised Psychiatrists , Healthcare Ltd , Peter Widdows , Incannex Director , Yarra Riverfront , Clarion Director , Seano Carroll , Chief Scientific Officer , Once Clarion , Royal Australian ,

Incannex Healthcare connects superannuation shareholders with independent advice amid US redomiciliation

Ahead of its intended transition to the Nasdaq, Incannex Healthcare Ltd (ASX:IHL, NASDAQ:IXHL) is offering shareholders the chance to engage with an. ....

United States , July Incannex , Joel Latham , Nasdaq Incannex Healthcare Ltd , Incannex Healthcare Ltd ,

Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement

28.07.2023 - MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) - Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is pleased to provide its quarterly activities report . ....

South Australia , United States , New Zealand , Joel Latham , Redomiciling Incannex , Peter Widdows , April Incannex , Drug Administration , Early Phase Clinical Research , Incannex Healthcare , Clinical Research , Iv Clinical Research , Quest Pharmaceutical Services , Clarion Clinics Group Pty Ltd , Human Research Ethics Committee , Clarion Clinics Group , European Union Medicines Agency , Corporate Governance Council Principles , Disclosure Committee , Apirx Pharmaceuticals , Incannex Healthcare Inc , Obstructive Sleep Apnoea , Obstructive Sleep , Investigational New Drug , Trial Investigating , Managing Director ,